Pharmacokinetics partly explains the relationship between carcinoembryonic antigen level and survival of colorectal cancer patients treated with ramucirumab

Eur J Cancer. 2018 Mar:92:119-120. doi: 10.1016/j.ejca.2017.12.004. Epub 2018 Jan 9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Biomarkers, Tumor
  • Carcinoembryonic Antigen*
  • Colorectal Neoplasms*
  • Humans
  • Ramucirumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Biomarkers, Tumor
  • Carcinoembryonic Antigen